Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Nuclear Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Nuclear Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Care

Published: 2025-02-09

Pages: 106 Pages

Report ld: 3678398

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Nuclear Medicine was estimated to be worth US$ 6875 million in 2024 and is forecast to a readjusted size of US$ 11090 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.

Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Nuclear Medicine Market Size(US$)

M= millions and B=billions

Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.

Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nuclear Medicine by region & country, by Type, and by Application.

The Nuclear Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.

Market Segmentation

Report Metric
Details
Report Title
Nuclear Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Forecasted Market Size in 2031
US$ 11090 million
CAGR(2025-2031)
7.4%
Market Size Available for Years
2025-2031
Global Nuclear Medicine Companies Covered
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
Global Nuclear Medicine Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nuclear Medicine Market, Segment by Type
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Global Nuclear Medicine Market, Segment by Application
Oncology
Thyroid
Cardiology
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nuclear Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Nuclear Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Nuclear Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Nuclear Medicine Product Introduction
    1.2 Global Nuclear Medicine Market Size Forecast (2020-2031)
    1.3 Nuclear Medicine Market Trends & Drivers
        1.3.1 Nuclear Medicine Industry Trends
        1.3.2 Nuclear Medicine Market Drivers & Opportunity
        1.3.3 Nuclear Medicine Market Challenges
        1.3.4 Nuclear Medicine Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Nuclear Medicine Players Revenue Ranking (2024)
    2.2 Global Nuclear Medicine Revenue by Company (2020-2025)
    2.3 Key Companies Nuclear Medicine Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Nuclear Medicine Product Offered
    2.5 Key Companies Time to Begin Mass Production of Nuclear Medicine
    2.6 Nuclear Medicine Market Competitive Analysis
        2.6.1 Nuclear Medicine Market Concentration Rate (2020-2025)
        2.6.2 Global 5 and 10 Largest Companies by Nuclear Medicine Revenue in 2024
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Diagnostic Nuclear Medicine
        3.1.2 Therapeutic Nuclear Medicine
    3.2 Global Nuclear Medicine Sales Value by Type
        3.2.1 Global Nuclear Medicine Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Nuclear Medicine Sales Value, by Type (2020-2031)
        3.2.3 Global Nuclear Medicine Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Oncology
        4.1.2 Thyroid
        4.1.3 Cardiology
        4.1.4 Others
    4.2 Global Nuclear Medicine Sales Value by Application
        4.2.1 Global Nuclear Medicine Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Nuclear Medicine Sales Value, by Application (2020-2031)
        4.2.3 Global Nuclear Medicine Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region
    5.1 Global Nuclear Medicine Sales Value by Region
        5.1.1 Global Nuclear Medicine Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Nuclear Medicine Sales Value by Region (2020-2025)
        5.1.3 Global Nuclear Medicine Sales Value by Region (2026-2031)
        5.1.4 Global Nuclear Medicine Sales Value by Region (%), (2020-2031)
    5.2 North America
        5.2.1 North America Nuclear Medicine Sales Value, 2020-2031
        5.2.2 North America Nuclear Medicine Sales Value by Country (%), 2024 VS 2031
    5.3 Europe
        5.3.1 Europe Nuclear Medicine Sales Value, 2020-2031
        5.3.2 Europe Nuclear Medicine Sales Value by Country (%), 2024 VS 2031
    5.4 Asia Pacific
        5.4.1 Asia Pacific Nuclear Medicine Sales Value, 2020-2031
        5.4.2 Asia Pacific Nuclear Medicine Sales Value by Region (%), 2024 VS 2031
    5.5 South America
        5.5.1 South America Nuclear Medicine Sales Value, 2020-2031
        5.5.2 South America Nuclear Medicine Sales Value by Country (%), 2024 VS 2031
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Nuclear Medicine Sales Value, 2020-2031
        5.6.2 Middle East & Africa Nuclear Medicine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Nuclear Medicine Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Nuclear Medicine Sales Value, 2020-2031
    6.3 United States
        6.3.1 United States Nuclear Medicine Sales Value, 2020-2031
        6.3.2 United States Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Nuclear Medicine Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Nuclear Medicine Sales Value, 2020-2031
        6.4.2 Europe Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Nuclear Medicine Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Nuclear Medicine Sales Value, 2020-2031
        6.5.2 China Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Nuclear Medicine Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Nuclear Medicine Sales Value, 2020-2031
        6.6.2 Japan Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Nuclear Medicine Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Nuclear Medicine Sales Value, 2020-2031
        6.7.2 South Korea Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Nuclear Medicine Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Nuclear Medicine Sales Value, 2020-2031
        6.8.2 Southeast Asia Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Nuclear Medicine Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Nuclear Medicine Sales Value, 2020-2031
        6.9.2 India Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Nuclear Medicine Sales Value by Application, 2024 VS 2031

7 Company Profiles
    7.1 Cardinal Health
        7.1.1 Cardinal Health Profile
        7.1.2 Cardinal Health Main Business
        7.1.3 Cardinal Health Nuclear Medicine Products, Services and Solutions
        7.1.4 Cardinal Health Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.1.5 Cardinal Health Recent Developments
    7.2 GE Healthcare
        7.2.1 GE Healthcare Profile
        7.2.2 GE Healthcare Main Business
        7.2.3 GE Healthcare Nuclear Medicine Products, Services and Solutions
        7.2.4 GE Healthcare Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.2.5 GE Healthcare Recent Developments
    7.3 Jubilant Pharma
        7.3.1 Jubilant Pharma Profile
        7.3.2 Jubilant Pharma Main Business
        7.3.3 Jubilant Pharma Nuclear Medicine Products, Services and Solutions
        7.3.4 Jubilant Pharma Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.3.5 Jubilant Pharma Recent Developments
    7.4 Novartis
        7.4.1 Novartis Profile
        7.4.2 Novartis Main Business
        7.4.3 Novartis Nuclear Medicine Products, Services and Solutions
        7.4.4 Novartis Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.4.5 Novartis Recent Developments
    7.5 Curium Pharma
        7.5.1 Curium Pharma Profile
        7.5.2 Curium Pharma Main Business
        7.5.3 Curium Pharma Nuclear Medicine Products, Services and Solutions
        7.5.4 Curium Pharma Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.5.5 Curium Pharma Recent Developments
    7.6 SIEMENS
        7.6.1 SIEMENS Profile
        7.6.2 SIEMENS Main Business
        7.6.3 SIEMENS Nuclear Medicine Products, Services and Solutions
        7.6.4 SIEMENS Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.6.5 SIEMENS Recent Developments
    7.7 Lantheus
        7.7.1 Lantheus Profile
        7.7.2 Lantheus Main Business
        7.7.3 Lantheus Nuclear Medicine Products, Services and Solutions
        7.7.4 Lantheus Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.7.5 Lantheus Recent Developments
    7.8 Bracco Imaging
        7.8.1 Bracco Imaging Profile
        7.8.2 Bracco Imaging Main Business
        7.8.3 Bracco Imaging Nuclear Medicine Products, Services and Solutions
        7.8.4 Bracco Imaging Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.8.5 Bracco Imaging Recent Developments
    7.9 Bayer
        7.9.1 Bayer Profile
        7.9.2 Bayer Main Business
        7.9.3 Bayer Nuclear Medicine Products, Services and Solutions
        7.9.4 Bayer Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.9.5 Bayer Recent Developments
    7.10 Eli Lilly
        7.10.1 Eli Lilly Profile
        7.10.2 Eli Lilly Main Business
        7.10.3 Eli Lilly Nuclear Medicine Products, Services and Solutions
        7.10.4 Eli Lilly Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.10.5 Eli Lilly Recent Developments
    7.11 Aurobindo Pharma
        7.11.1 Aurobindo Pharma Profile
        7.11.2 Aurobindo Pharma Main Business
        7.11.3 Aurobindo Pharma Nuclear Medicine Products, Services and Solutions
        7.11.4 Aurobindo Pharma Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.11.5 Aurobindo Pharma Recent Developments
    7.12 Mundipharma
        7.12.1 Mundipharma Profile
        7.12.2 Mundipharma Main Business
        7.12.3 Mundipharma Nuclear Medicine Products, Services and Solutions
        7.12.4 Mundipharma Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.12.5 Mundipharma Recent Developments
    7.13 China Isotope & Radiation
        7.13.1 China Isotope & Radiation Profile
        7.13.2 China Isotope & Radiation Main Business
        7.13.3 China Isotope & Radiation Nuclear Medicine Products, Services and Solutions
        7.13.4 China Isotope & Radiation Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.13.5 China Isotope & Radiation Recent Developments
    7.14 Yantai Dongcheng
        7.14.1 Yantai Dongcheng Profile
        7.14.2 Yantai Dongcheng Main Business
        7.14.3 Yantai Dongcheng Nuclear Medicine Products, Services and Solutions
        7.14.4 Yantai Dongcheng Nuclear Medicine Revenue (US$ Million) & (2020-2025)
        7.14.5 Yantai Dongcheng Recent Developments

8 Industry Chain Analysis
    8.1 Nuclear Medicine Industrial Chain
    8.2 Nuclear Medicine Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Nuclear Medicine Sales Model
        8.5.2 Sales Channel
        8.5.3 Nuclear Medicine Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Nuclear Medicine Market Trends
 Table 2. Nuclear Medicine Market Drivers & Opportunity
 Table 3. Nuclear Medicine Market Challenges
 Table 4. Nuclear Medicine Market Restraints
 Table 5. Global Nuclear Medicine Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Nuclear Medicine Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Nuclear Medicine Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Nuclear Medicine Product Type
 Table 9. Key Companies Time to Begin Mass Production of Nuclear Medicine
 Table 10. Global Nuclear Medicine Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Nuclear Medicine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Nuclear Medicine Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Nuclear Medicine Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Nuclear Medicine Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Nuclear Medicine Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Nuclear Medicine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Nuclear Medicine Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Nuclear Medicine Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Nuclear Medicine Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Nuclear Medicine Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Nuclear Medicine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Nuclear Medicine Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Nuclear Medicine Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Nuclear Medicine Sales Value by Region (2020-2025) & (%)
 Table 27. Global Nuclear Medicine Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Nuclear Medicine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Nuclear Medicine Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Nuclear Medicine Sales Value, (2026-2031) & (US$ Million)
 Table 31. Cardinal Health Basic Information List
 Table 32. Cardinal Health Description and Business Overview
 Table 33. Cardinal Health Nuclear Medicine Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Nuclear Medicine Business of Cardinal Health (2020-2025)
 Table 35. Cardinal Health Recent Developments
 Table 36. GE Healthcare Basic Information List
 Table 37. GE Healthcare Description and Business Overview
 Table 38. GE Healthcare Nuclear Medicine Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Nuclear Medicine Business of GE Healthcare (2020-2025)
 Table 40. GE Healthcare Recent Developments
 Table 41. Jubilant Pharma Basic Information List
 Table 42. Jubilant Pharma Description and Business Overview
 Table 43. Jubilant Pharma Nuclear Medicine Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Nuclear Medicine Business of Jubilant Pharma (2020-2025)
 Table 45. Jubilant Pharma Recent Developments
 Table 46. Novartis Basic Information List
 Table 47. Novartis Description and Business Overview
 Table 48. Novartis Nuclear Medicine Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Nuclear Medicine Business of Novartis (2020-2025)
 Table 50. Novartis Recent Developments
 Table 51. Curium Pharma Basic Information List
 Table 52. Curium Pharma Description and Business Overview
 Table 53. Curium Pharma Nuclear Medicine Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Nuclear Medicine Business of Curium Pharma (2020-2025)
 Table 55. Curium Pharma Recent Developments
 Table 56. SIEMENS Basic Information List
 Table 57. SIEMENS Description and Business Overview
 Table 58. SIEMENS Nuclear Medicine Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Nuclear Medicine Business of SIEMENS (2020-2025)
 Table 60. SIEMENS Recent Developments
 Table 61. Lantheus Basic Information List
 Table 62. Lantheus Description and Business Overview
 Table 63. Lantheus Nuclear Medicine Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Nuclear Medicine Business of Lantheus (2020-2025)
 Table 65. Lantheus Recent Developments
 Table 66. Bracco Imaging Basic Information List
 Table 67. Bracco Imaging Description and Business Overview
 Table 68. Bracco Imaging Nuclear Medicine Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Nuclear Medicine Business of Bracco Imaging (2020-2025)
 Table 70. Bracco Imaging Recent Developments
 Table 71. Bayer Basic Information List
 Table 72. Bayer Description and Business Overview
 Table 73. Bayer Nuclear Medicine Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Nuclear Medicine Business of Bayer (2020-2025)
 Table 75. Bayer Recent Developments
 Table 76. Eli Lilly Basic Information List
 Table 77. Eli Lilly Description and Business Overview
 Table 78. Eli Lilly Nuclear Medicine Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Nuclear Medicine Business of Eli Lilly (2020-2025)
 Table 80. Eli Lilly Recent Developments
 Table 81. Aurobindo Pharma Basic Information List
 Table 82. Aurobindo Pharma Description and Business Overview
 Table 83. Aurobindo Pharma Nuclear Medicine Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Nuclear Medicine Business of Aurobindo Pharma (2020-2025)
 Table 85. Aurobindo Pharma Recent Developments
 Table 86. Mundipharma Basic Information List
 Table 87. Mundipharma Description and Business Overview
 Table 88. Mundipharma Nuclear Medicine Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Nuclear Medicine Business of Mundipharma (2020-2025)
 Table 90. Mundipharma Recent Developments
 Table 91. China Isotope & Radiation Basic Information List
 Table 92. China Isotope & Radiation Description and Business Overview
 Table 93. China Isotope & Radiation Nuclear Medicine Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Nuclear Medicine Business of China Isotope & Radiation (2020-2025)
 Table 95. China Isotope & Radiation Recent Developments
 Table 96. Yantai Dongcheng Basic Information List
 Table 97. Yantai Dongcheng Description and Business Overview
 Table 98. Yantai Dongcheng Nuclear Medicine Products, Services and Solutions
 Table 99. Revenue (US$ Million) in Nuclear Medicine Business of Yantai Dongcheng (2020-2025)
 Table 100. Yantai Dongcheng Recent Developments
 Table 101. Key Raw Materials Lists
 Table 102. Raw Materials Key Suppliers Lists
 Table 103. Nuclear Medicine Downstream Customers
 Table 104. Nuclear Medicine Distributors List
 Table 105. Research Programs/Design for This Report
 Table 106. Key Data Information from Secondary Sources
 Table 107. Key Data Information from Primary Sources


List of Figures
 Figure 1. Nuclear Medicine Product Picture
 Figure 2. Global Nuclear Medicine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Nuclear Medicine Sales Value (2020-2031) & (US$ Million)
 Figure 4. Nuclear Medicine Report Years Considered
 Figure 5. Global Nuclear Medicine Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Nuclear Medicine Revenue in 2024
 Figure 7. Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. Diagnostic Nuclear Medicine Picture
 Figure 9. Therapeutic Nuclear Medicine Picture
 Figure 10. Global Nuclear Medicine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 11. Global Nuclear Medicine Sales Value Market Share by Type, 2024 & 2031
 Figure 12. Product Picture of Oncology
 Figure 13. Product Picture of Thyroid
 Figure 14. Product Picture of Cardiology
 Figure 15. Product Picture of Others
 Figure 16. Global Nuclear Medicine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 17. Global Nuclear Medicine Sales Value Market Share by Application, 2024 & 2031
 Figure 18. North America Nuclear Medicine Sales Value (2020-2031) & (US$ Million)
 Figure 19. North America Nuclear Medicine Sales Value by Country (%), 2024 VS 2031
 Figure 20. Europe Nuclear Medicine Sales Value, (2020-2031) & (US$ Million)
 Figure 21. Europe Nuclear Medicine Sales Value by Country (%), 2024 VS 2031
 Figure 22. Asia Pacific Nuclear Medicine Sales Value, (2020-2031) & (US$ Million)
 Figure 23. Asia Pacific Nuclear Medicine Sales Value by Region (%), 2024 VS 2031
 Figure 24. South America Nuclear Medicine Sales Value, (2020-2031) & (US$ Million)
 Figure 25. South America Nuclear Medicine Sales Value by Country (%), 2024 VS 2031
 Figure 26. Middle East & Africa Nuclear Medicine Sales Value, (2020-2031) & (US$ Million)
 Figure 27. Middle East & Africa Nuclear Medicine Sales Value by Country (%), 2024 VS 2031
 Figure 28. Key Countries/Regions Nuclear Medicine Sales Value (%), (2020-2031)
 Figure 29. United States Nuclear Medicine Sales Value, (2020-2031) & (US$ Million)
 Figure 30. United States Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
 Figure 31. United States Nuclear Medicine Sales Value by Application (%), 2024 VS 2031
 Figure 32. Europe Nuclear Medicine Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Europe Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
 Figure 34. Europe Nuclear Medicine Sales Value by Application (%), 2024 VS 2031
 Figure 35. China Nuclear Medicine Sales Value, (2020-2031) & (US$ Million)
 Figure 36. China Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
 Figure 37. China Nuclear Medicine Sales Value by Application (%), 2024 VS 2031
 Figure 38. Japan Nuclear Medicine Sales Value, (2020-2031) & (US$ Million)
 Figure 39. Japan Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
 Figure 40. Japan Nuclear Medicine Sales Value by Application (%), 2024 VS 2031
 Figure 41. South Korea Nuclear Medicine Sales Value, (2020-2031) & (US$ Million)
 Figure 42. South Korea Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
 Figure 43. South Korea Nuclear Medicine Sales Value by Application (%), 2024 VS 2031
 Figure 44. Southeast Asia Nuclear Medicine Sales Value, (2020-2031) & (US$ Million)
 Figure 45. Southeast Asia Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
 Figure 46. Southeast Asia Nuclear Medicine Sales Value by Application (%), 2024 VS 2031
 Figure 47. India Nuclear Medicine Sales Value, (2020-2031) & (US$ Million)
 Figure 48. India Nuclear Medicine Sales Value by Type (%), 2024 VS 2031
 Figure 49. India Nuclear Medicine Sales Value by Application (%), 2024 VS 2031
 Figure 50. Nuclear Medicine Industrial Chain
 Figure 51. Nuclear Medicine Manufacturing Cost Structure
 Figure 52. Channels of Distribution (Direct Sales, and Distribution)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed

Description

The global market for Nuclear Medicine was estimated to be worth US$ 6875 million in 2024 and is forecast to a readjusted size of US$ 11090 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.

Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.

Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nuclear Medicine by region & country, by Type, and by Application.

The Nuclear Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.

Market Segmentation

Related Reports

Global Nuclear Medicine Market Research Report 2024
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Published: 2024-01-03
Pages: 87
USD 2900.00
(Single User License)
Nuclear Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Published: 2024-01-06
Pages: 109
USD 3950.00
(Single User License)
Global Nuclear Medicine Market Research Report 2025
The global market for Nuclear Medicine was valued at US$ 6875 million in the year 2024 and is projected to reach a revised size of US$ 11090 million by 2031, growing at a CAGR of 7.4% during the forecast period.
Published: 2025-02-09
Pages: 83
USD 2900.00
(Single User License)
Nuclear Medicine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nuclear Medicine was estimated to be worth US$ 7131 million in 2024 and is forecast to a readjusted size of US$ 11670 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 109
USD 3950.00
(Single User License)
Global Nuclear Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nuclear Medicine market size was US$ 6875 million in 2024 and is forecast to a readjusted size of US$ 11090 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 97
USD 4250.00
(Single User License)
Global Nuclear Medicine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Nuclear Medicine was estimated to be worth US$ 6875 million and is forecast to reach approximately US$ 11090 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 144
USD 5900.00
(Single User License)
Global Nuclear Medicine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nuclear Medicine market is projected to grow from US$ 6875 million in 2024 to US$ 11090 million by 2031, at a CAGR of 7.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 133
USD 4900.00
(Single User License)
Nuclear Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nuclear Medicine was estimated to be worth US$ 7224 million in 2025 and is projected to reach US$ 11830 million, growing at a CAGR of 7.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
USD 3950.00
(Single User License)
Global Nuclear Medicine Market Research Report 2026
The global Nuclear Medicine market was valued at US$ 7224 million in 2025 and is anticipated to reach US$ 11830 million by 2032, at a CAGR of 7.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 111
USD 2900.00
(Single User License)
Global Nuclear Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nuclear Medicine market size was US$ 7224 million in 2025 and is forecast to reach a readjusted size of US$ 11830 million by 2032 with a CAGR of 7.4% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 98
USD 4250.00
(Single User License)

Global Nuclear Medicine Market Research Report 2024
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Published: 2024-01-03
Pages: 87
USD 2900.00 ()
Nuclear Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Published: 2024-01-06
Pages: 109
USD 3950.00 ()
Global Nuclear Medicine Market Research Report 2025
The global market for Nuclear Medicine was valued at US$ 6875 million in the year 2024 and is projected to reach a revised size of US$ 11090 million by 2031, growing at a CAGR of 7.4% during the forecast period.
Published: 2025-02-09
Pages: 83
USD 2900.00 ()
Nuclear Medicine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nuclear Medicine was estimated to be worth US$ 7131 million in 2024 and is forecast to a readjusted size of US$ 11670 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 109
USD 3950.00 ()
Global Nuclear Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nuclear Medicine market size was US$ 6875 million in 2024 and is forecast to a readjusted size of US$ 11090 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 97
USD 4250.00 ()
Global Nuclear Medicine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Nuclear Medicine was estimated to be worth US$ 6875 million and is forecast to reach approximately US$ 11090 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 144
USD 5900.00 ()
Global Nuclear Medicine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nuclear Medicine market is projected to grow from US$ 6875 million in 2024 to US$ 11090 million by 2031, at a CAGR of 7.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 133
USD 4900.00 ()
Nuclear Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nuclear Medicine was estimated to be worth US$ 7224 million in 2025 and is projected to reach US$ 11830 million, growing at a CAGR of 7.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
USD 3950.00 ()
Global Nuclear Medicine Market Research Report 2026
The global Nuclear Medicine market was valued at US$ 7224 million in 2025 and is anticipated to reach US$ 11830 million by 2032, at a CAGR of 7.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 111
USD 2900.00 ()
Global Nuclear Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nuclear Medicine market size was US$ 7224 million in 2025 and is forecast to reach a readjusted size of US$ 11830 million by 2032 with a CAGR of 7.4% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 98
USD 4250.00 ()